tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Technical Analysis

Compare
801 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Immunovant’s (IMVT) Moving Averages Convergence Divergence (MACD) indicator is -0.87, suggesting Immunovant is a Sell.
Immunovant’s (IMVT) 20-Day exponential moving average is 21.18, while Immunovant’s (IMVT) share price is $20.45, making it a Buy.
Immunovant’s (IMVT) 50-Day exponential moving average is 23.14, while Immunovant’s (IMVT) share price is $20.45, making it a Sell.

Immunovant (IMVT) Pivot Points

Feb 22, 2025, 04:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.25
19.83
20.14
20.72
21.03
21.61
21.92
Fibonacci
19.83
20.17
20.38
20.72
21.06
21.27
21.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunovant (IMVT) Moving Averages

Feb 22, 2025, 04:10 PM
Period
Simple
Exponential
MA5
20.74Buy
20.73Buy
MA10
20.20Buy
20.66Buy
MA20
20.98Buy
21.18Buy
MA50
23.57Sell
23.14Sell
MA100
26.26Sell
25.17Sell
MA200
27.56Sell
27.01Sell
Immunovant’s (IMVT) 10-Day exponential moving average is 20.66, while Immunovant’s (IMVT) share price is $20.45, making it a Buy.
Immunovant’s (IMVT) 100-Day exponential moving average is 25.17, while Immunovant’s (IMVT) share price is $20.45, making it a Sell.
Immunovant’s (IMVT) stock price is $20.45 and Immunovant’s (IMVT) 50-day simple moving average is 23.57, creating a Sell signal.
Immunovant’s (IMVT) stock price is $20.45 and Immunovant’s (IMVT) 100-day simple moving average is 26.26, creating a Sell signal.
Immunovant’s (IMVT) stock price is $20.45 and Immunovant’s (IMVT) 200-day simple moving average is 27.56, creating a Sell signal.

Immunovant (IMVT) Technical Indicators

Feb 22, 2025, 04:10 PM
Name
Value
Implied Action
RSI (14)
47.12
Neutral
STOCH (9,6)
62.26
Neutral
STOCHRSI (14)
44.03
Neutral
MACD (12,26)
-0.87
Sell
ADX (14)
21.64
Neutral
Williams %R
-45.48
Buy
CCI (14)
12.17
Neutral
ATR (14)
1.09
-
Ultimate Oscillator
45.42
Neutral
ROC
-2.16
Sell
Immunovant’s (IMVT) Relative Strength Index (RSI) is 47.12, creating a Neutral signal.
Immunovant’s (IMVT) Trend Strength Indicator (ADX) is 21.64, creating a Neutral signal.
Immunovant’s (IMVT) Commodity Channel Index (CCI) is 12.17, creating a Neutral signal.
Immunovant’s (IMVT) Price Rate of Change (ROC) is -2.16, creating a Sell signal.

FAQ

Is IMVT a Buy, Hold, or Sell?
Based on IMVT’s technical indicators, IMVT is a Hold.
    What is IMVT’s RSI (14)?
    IMVT’s RSI (14) is 47.12, which suggests IMVT is a Neutral.
      What is IMVT’s MACD?
      IMVT’s MACD is -0.87, which suggests IMVT is a Sell.
        What is IMVT’s 5-day moving average?
        IMVT’s 5-day moving average is 20.74, which suggests IMVT is a Buy.
          What is IMVT’s 20-day moving average?
          IMVT 20-day moving average is 20.98, which suggests IMVT is a Buy.
            What is IMVT’s 50-day moving average?
            IMVT’s 50-day moving average is 23.57, which suggests IMVT is a Sell.
              What is IMVT’s 200-day moving average?
              IMVT’s 200-day moving average is 27.56, which suggests IMVT is a Sell.
                What is IMVT’s Williams % R (14)?
                IMVT’s Williams % R (14) is -45.48, which suggests IMVT is a Buy.
                  What is IMVT’s CCI (14)?
                  IMVT’s CCI (14) is 12.17, which suggests IMVT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis